Hepatitis c virus Trials in Los Angeles, United States
Conditions / Hepatitis c virus / Los Angeles, United States
Clinical trials for Hepatitis c virus investigate a range of treatment strategies and patient populations.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02103699 | A Study to Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With Simeprevir | COMPLETED | — |
| NCT01125189 | Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients | COMPLETED | PHASE2 |
| NCT00678587 | Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures | TERMINATED | PHASE3 |
| NCT01581203 | Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives) | COMPLETED | PHASE3 |
| NCT01188772 | Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients | COMPLETED | PHASE2 |
| NCT02073656 | Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection | COMPLETED | PHASE3 |
| NCT01306617 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection | COMPLETED | PHASE2 |
| NCT01598090 | Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir | COMPLETED | PHASE3 |
| NCT01573351 | Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials) | COMPLETED | PHASE3 |
| NCT01170962 | Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment | COMPLETED | PHASE2 |